K23 Novel Interventions for Alcohol Dependent Frequent ED Users

K23 针对酒精依赖频繁 ED 用户的新颖干预措施

基本信息

项目摘要

DESCRIPTION (provided by applicant): The PI, Ryan McCormack, MD, is an emergency medicine physician whose broad clinical background and research experience, including board certification in Emergency, Internal, and Addiction Medicine, reflects his commitment to integrating health services using collaborative, patient-oriented approaches to enhance healthcare quality for individuals with alcohol use disorders (AUDs). His preliminary research has focused on alcohol dependent frequent emergency department (ED) users, a vulnerable population that has a disproportionate impact on healthcare and societal costs. These individuals are difficult to engage in their personal health and often receive care exclusively in EDs, rather than settings offering treatment for addiction and other chronic conditions. Despite its prevalence, treatment for AUDs is rarely initiated in the ED, and research to develop and implement effective interventions is even less common. Dr. McCormack adapted a validated algorithm to identify this target population and developed and tested a multidisciplinary, care management (CM) intervention that coordinates health and social services using existing resources through collaboration with public health agencies. He demonstrated feasibility and promising outcomes, including housing placement and reduced ED and inpatient use and mortality compared to controls. His proposed research will incorporate efficacious pharmacotherapy in the form of extended-release naltrexone (XR-NTX) to this intervention. Fifty participants will be randomized to receive XR-NTX+CM or standard care, which will be initiated in the ED and continued through coordination of care across departments and partnering agencies. He will assess feasibility and acceptability of implementing this intervention and of rigorously testing its 6- and 12- month effect on healthcare utilization and heavy drinking. Information gathered on its delivery as well as process evaluations and refinements will inform subsequent effectiveness-implementation trials. This K23 award will support Dr. McCormack in advanced research training and mentoring, allowing him to conduct his proposed research, which will form the basis for an R01 application on studies that integrate alcohol treatment in diverse clinical settings. His career development also includes structured mentorship and apprenticeships, comprehensive didactic training, as well as participation in academic conferences, research group meetings and studies, and reporting findings. Through his partnership with several public health agencies, the infrastructure of NYU, and his team of experienced and accomplished mentors that span emergency and internal medicine, psychiatry, population health, Dr. McCormack is well-positioned to become an independent investigator committed to developing and testing models of intervention and disseminating innovative practices and policies across health systems. The trans-disciplinary, collaborative nature of his work and his aim "to improve the effectiveness, efficiency and equity of services designed to reduce the public health burden of AUDs" are well aligned with the Mission and Vision of NIAAA.
描述(由申请人提供):PI,Ryan McCormack,医学博士是一名急诊医学医师,其广泛的临床背景和研究经验,包括急诊,内部和成瘾医学的董事会认证,反映了他对使用协作,以患者为方便的方法来整合卫生服务的承诺,以增强酒精使用调情患者的医疗质量(AUDES)。他的初步研究集中在依赖酒精的急诊室(ED)用户上,这是一个脆弱的人群,对医疗保健和社会成本的影响不成比例。这些人很难从事个人健康,并且经常在ED中获得护理,而不是为成瘾和其他慢性病提供治疗。尽管它的盛行率很高,但在ED中很少开始使用AUD的治疗,而开发和实施有效干预措施的研究甚至不太常见。 McCormack博士改编了经过验证的算法,以识别该目标人群,并开发和测试了多学科的护理管理(CM)干预措施,该干预措施通过与公共卫生机构的合作使用现有资源来协调健康和社会服务。与对照组相比,他证明了可行性和有希望的结果,包括住房位置以及减少的ED和住院使用和死亡率。他提出的研究将以扩展释放的纳曲酮(XR-NTX)的形式融合有效的药物治疗,以进行此干预措施。五十名参与者将被随机接收XR-NTX+CM或标准护理,这些参与者将在ED中启动,并通过各部门和合作机构的护理进行协调。他将评估实施这种干预措施的可行性和可接受性,并严格测试其6个月和12个月对医疗保健利用和大量饮酒的影响。收集的有关其交付以及过程评估和改进的信息将为随后的有效性试验提供信息。该K23奖将支持McCormack博士在高级研究培训和指导中,使他能够进行拟议的研究,这将构成R01在不同临床环境中整合酒精治疗的研究的基础。他的职业发展还包括结构化指导和学徒制,全面的教学培训,以及参加学术会议,研究小组会议和研究以及报告结果。通过与几个公共卫生机构,纽约大学的基础设施以及他的经验丰富和有成就的导师团队的合作关系,麦考马克博士凭借良好的态度,成为一个独立的研究人员,致力于开发和测试干预和测试跨健康系统的独立研究人员。他的工作的跨学科,协作性质和他的目标“旨在提高旨在减轻AUDS公共健康负担的服务的有效性,效率和公平性”与NIAAA的使命和愿景非常吻合。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Ryan P McCormack其他文献

Ryan P McCormack的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Ryan P McCormack', 18)}}的其他基金

Measuring Improvement in the Quality of ED-initiated Treatment for OUD using Observation
使用观察来衡量 ED 发起的 OUD 治疗质量的改善
  • 批准号:
    10186872
  • 财政年份:
    2020
  • 资助金额:
    $ 18.54万
  • 项目类别:
Measuring Improvement in the Quality of ED-initiated Treatment for OUD using Observation
使用观察来衡量 ED 发起的 OUD 治疗质量的改善
  • 批准号:
    10459308
  • 财政年份:
    2020
  • 资助金额:
    $ 18.54万
  • 项目类别:
Measuring Improvement in the Quality of ED-initiated Treatment for OUD using Observation
使用观察来衡量 ED 发起的 OUD 治疗质量的改善
  • 批准号:
    10676110
  • 财政年份:
    2020
  • 资助金额:
    $ 18.54万
  • 项目类别:
Measuring Improvement in the Quality of ED-initiated Treatment for OUD using Observation
使用观察来衡量 ED 发起的 OUD 治疗质量的改善
  • 批准号:
    10223255
  • 财政年份:
    2020
  • 资助金额:
    $ 18.54万
  • 项目类别:
K23 Novel Interventions for Alcohol Dependent Frequent ED Users
K23 针对酒精依赖频繁 ED 用户的新颖干预措施
  • 批准号:
    8679111
  • 财政年份:
    2014
  • 资助金额:
    $ 18.54万
  • 项目类别:
K23 Novel Interventions for Alcohol Dependent Frequent ED Users
K23 针对酒精依赖频繁 ED 用户的新颖干预措施
  • 批准号:
    8924894
  • 财政年份:
    2014
  • 资助金额:
    $ 18.54万
  • 项目类别:
K23 Novel Interventions for Alcohol Dependent Frequent ED Users
K23 针对酒精依赖频繁 ED 用户的新颖干预措施
  • 批准号:
    9323215
  • 财政年份:
    2014
  • 资助金额:
    $ 18.54万
  • 项目类别:

相似国自然基金

签字注册会计师动态配置问题研究:基于临阵换师视角
  • 批准号:
    72362023
  • 批准年份:
    2023
  • 资助金额:
    28 万元
  • 项目类别:
    地区科学基金项目
全生命周期视域的会计师事务所分所一体化治理与审计风险控制研究
  • 批准号:
    72372064
  • 批准年份:
    2023
  • 资助金额:
    40 万元
  • 项目类别:
    面上项目
会计师事务所数字化能力构建:动机、经济后果及作用机制
  • 批准号:
    72372028
  • 批准年份:
    2023
  • 资助金额:
    42.00 万元
  • 项目类别:
    面上项目
会计师事务所薪酬激励机制:理论框架、激励效应检验与优化重构
  • 批准号:
    72362001
  • 批准年份:
    2023
  • 资助金额:
    28.00 万元
  • 项目类别:
    地区科学基金项目
环境治理目标下的公司财务、会计和审计行为研究
  • 批准号:
    72332002
  • 批准年份:
    2023
  • 资助金额:
    165.00 万元
  • 项目类别:
    重点项目

相似海外基金

Detecting Adolescent Suicidality Biometric Signals and Dynamic Variability with Wearable Technology
利用可穿戴技术检测青少年自杀生物特征信号和动态变异性
  • 批准号:
    10731651
  • 财政年份:
    2023
  • 资助金额:
    $ 18.54万
  • 项目类别:
Elucidating Non-Routine Events Arising from Interhospital Transfers
阐明院间转移引起的非常规事件
  • 批准号:
    10749448
  • 财政年份:
    2023
  • 资助金额:
    $ 18.54万
  • 项目类别:
Screen Smart: Using Digital Health to Improve HIV Screening and Prevention for Adolescents in the Emergency Department
智能屏幕:利用数字健康改善急诊科青少年的艾滋病毒筛查和预防
  • 批准号:
    10711679
  • 财政年份:
    2023
  • 资助金额:
    $ 18.54万
  • 项目类别:
Identifying patient subgroups and processes of care that cause outcome differences following ICU vs. ward triage among patients with acute respiratory failure and sepsis
确定急性呼吸衰竭和脓毒症患者在 ICU 与病房分诊后导致结局差异的患者亚组和护理流程
  • 批准号:
    10734357
  • 财政年份:
    2023
  • 资助金额:
    $ 18.54万
  • 项目类别:
ERIS - Effective Reserve In Stroke
ERIS - 有效储备冲程
  • 批准号:
    10724761
  • 财政年份:
    2023
  • 资助金额:
    $ 18.54万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了